OSI Systems (NASDAQ:OSIS) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 11.6%
OSI Systems (NASDAQ:OSIS) reported Q2 CY2026 sales of $484.1M, down 4.1% YoY, missing estimates. Full-year revenue guidance of $1.90B is 2% below analysts' expectations. Non-GAAP EPS of $3.78 met estimates. The stock dropped 11.6% post-earnings.
How this was made
The 30-second read
Why it matters
The earnings miss and lowered guidance suggest short‑term weakness, but stable margins and share buybacks provide some upside potential.
Market read
The earnings miss triggered an 11.6% stock decline, making the news highly relevant for traders with exposure to OSIS or the broader security‑tech sector.
What to watch
Adjusted operating margin remained stable at 15.3% and share buybacks reduced share count, which may support longer‑term earnings per share growth.
Background
OSI Systems provides security screening and patient monitoring equipment; its Q2 results were released on Aug 20, 2026.
Ticker impact
Q2 CY2026 revenue of $484.1M missed estimates and full-year guidance fell 2% below forecasts, causing the stock to drop 11.6% after the release.
Further downside pressure with potential for continued volatility; short‑term sell signal.
The miss is material, the stock already fell >11% on the news, and guidance remains below consensus, indicating near‑term weakness.
Market effects
Security and healthcare tech peers may see relative strength as OSIS underperforms.
U.S. tech sector may face slight drag in the afternoon session.
Limited; primarily impacts U.S. security‑screening and medical‑device niche.
Counterpoint
The stock's sharp drop could present a value entry if the market overreacts to a single quarter.
Key entities
- CompanyOSI Systems
Security and healthcare technology firm reporting Q2 CY2026 results.
